Extendicare Inc. (TSE:EXE – Get Free Report) hit a new 52-week high during trading on Wednesday . The company traded as high as C$16.44 and last traded at C$16.40, with a volume of 34529 shares trading hands. The stock had previously closed at C$16.13.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on EXE shares. CIBC set a C$18.00 price objective on Extendicare and gave the company an “outperform” rating in a report on Monday, September 22nd. National Bank Financial raised shares of Extendicare to a “strong-buy” rating in a research note on Wednesday, July 16th. Cibc World Mkts raised Extendicare to a “strong-buy” rating in a research note on Monday, September 22nd. Finally, National Bankshares upped their target price on shares of Extendicare from C$16.10 to C$17.50 and gave the company an “outperform” rating in a research report on Wednesday, October 8th. Two analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of C$15.20.
Read Our Latest Report on Extendicare
Extendicare Stock Down 1.6%
Extendicare Dividend Announcement
The company also recently announced a monthly dividend, which will be paid on Monday, November 17th. Investors of record on Monday, November 17th will be paid a $0.042 dividend. The ex-dividend date of this dividend is Friday, October 31st. This represents a c) annualized dividend and a dividend yield of 3.1%. Extendicare’s dividend payout ratio (DPR) is currently 50.57%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- How to Evaluate a Stock Before Buying
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- What is a SEC Filing?
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- Growth Stocks: What They Are, Examples and How to Invest
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
